GLPwatch
Eli Lilly
LLY · GLP-1 products, pipeline, and financials
Approved GLP-1 products (3)
Molecules (5)
Revenue (SEC) SEC EDGAR ↗
| Concept | Period end | Value | Form |
|---|---|---|---|
| Revenue | 2025-12-31 | $65.2B | 10-K |
| Revenue | 2024-12-31 | $45.0B | 10-K |
| Revenue | 2023-12-31 | $34.1B | 10-K |
| Revenue | 2022-12-31 | $28.5B | 10-K |
| Revenue | 2021-12-31 | $28.3B | 10-K |
| Revenue | 2020-12-31 | $24.5B | 10-K |
| Revenue | 2019-12-31 | $22.3B | 10-K |
| Revenue | 2019-09-30 | $5.5B | 10-K |